454 related articles for article (PubMed ID: 27890923)
1. The epigenetic landscape of renal cancer.
Morris MR; Latif F
Nat Rev Nephrol; 2017 Jan; 13(1):47-60. PubMed ID: 27890923
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic regulation in RCC: opportunities for therapeutic intervention?
Larkin J; Goh XY; Vetter M; Pickering L; Swanton C
Nat Rev Urol; 2012 Jan; 9(3):147-55. PubMed ID: 22249190
[TBL] [Abstract][Full Text] [Related]
3. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
4. Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer.
Banks RE; Tirukonda P; Taylor C; Hornigold N; Astuti D; Cohen D; Maher ER; Stanley AJ; Harnden P; Joyce A; Knowles M; Selby PJ
Cancer Res; 2006 Feb; 66(4):2000-11. PubMed ID: 16488999
[TBL] [Abstract][Full Text] [Related]
5. Alcohol consumption and mutations or promoter hypermethylation of the von Hippel-Lindau gene in renal cell carcinoma.
Schouten LJ; van Dijk BA; Oosterwijk E; van Engeland M; Hulsbergen-van de Kaa CA; Kiemeney LA; Goldbohm RA; Kester A; de Vogel S; Schalken JA; van den Brandt PA
Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3543-50. PubMed ID: 19064569
[TBL] [Abstract][Full Text] [Related]
6. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning.
Hinshelwood RA; Melki JR; Huschtscha LI; Paul C; Song JZ; Stirzaker C; Reddel RR; Clark SJ
Hum Mol Genet; 2009 Aug; 18(16):3098-109. PubMed ID: 19477956
[TBL] [Abstract][Full Text] [Related]
7. Unique molecular alteration patterns in von Hippel-Lindau (VHL) gene in a cohort of sporadic renal cell carcinoma patients from Pakistan.
Khaliq S; Ajaz S; Firasat S; Shahid S; Hasan AS; Sultan G; Mohsin R; Hashmi A; Mubarak M; Naqvi SA; Rizvi SA; Mehdi SQ; Abid A
Mutat Res; 2014; 763-764():45-52. PubMed ID: 24727139
[TBL] [Abstract][Full Text] [Related]
8. Loss of PBRM1 expression is associated with renal cell carcinoma progression.
Pawłowski R; Mühl SM; Sulser T; Krek W; Moch H; Schraml P
Int J Cancer; 2013 Jan; 132(2):E11-7. PubMed ID: 22949125
[TBL] [Abstract][Full Text] [Related]
9. [Methylation in the Regulation of the Expression of Chromosome 3 and microRNA Genes in Clear-Cell Renal Cell Carcinomas].
Braga EA; Khodyrev DS; Loginov VI; Pronina IV; Senchenko VN; Dmitriev AA; Kubatiev AA; Kushlinskii NE
Genetika; 2015 Jun; 51(6):668-84. PubMed ID: 26310030
[TBL] [Abstract][Full Text] [Related]
10. [Epigenetic alterations in kidney cancers].
Helleux A; Debien V; Fadloun A; Rippinger M; Lebedinsky S; Davidson I; Malouf GG
Bull Cancer; 2019 Oct; 106(10):839-841. PubMed ID: 31451188
[No Abstract] [Full Text] [Related]
11. Wnt antagonist DICKKOPF-3 (Dkk-3) induces apoptosis in human renal cell carcinoma.
Ueno K; Hirata H; Majid S; Chen Y; Zaman MS; Tabatabai ZL; Hinoda Y; Dahiya R
Mol Carcinog; 2011 Jun; 50(6):449-57. PubMed ID: 21268126
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic regulation of microRNA expression in renal cell carcinoma.
Schiffgen M; Schmidt DH; von Rücker A; Müller SC; Ellinger J
Biochem Biophys Res Commun; 2013 Jun; 436(1):79-84. PubMed ID: 23707942
[TBL] [Abstract][Full Text] [Related]
13. Genetic and epigenetic alterations in the von hippel-lindau gene: the influence on renal cancer prognosis.
Smits KM; Schouten LJ; van Dijk BA; Hulsbergen-van de Kaa CA; Wouters KA; Oosterwijk E; van Engeland M; van den Brandt PA
Clin Cancer Res; 2008 Feb; 14(3):782-7. PubMed ID: 18245539
[TBL] [Abstract][Full Text] [Related]
14. Von Hippel-Lindau disease and sporadic renal cell carcinoma.
Zbar B
Cancer Surv; 1995; 25():219-32. PubMed ID: 8718521
[TBL] [Abstract][Full Text] [Related]
15. Cancer chemoprevention and nutriepigenetics: state of the art and future challenges.
Gerhauser C
Top Curr Chem; 2013; 329():73-132. PubMed ID: 22955508
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic modifiers: activities in renal cell carcinoma.
de Cubas AA; Rathmell WK
Nat Rev Urol; 2018 Oct; 15(10):599-614. PubMed ID: 30030490
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of tumorigenesis of renal carcinomas associated with the constitutional chromosome 3;8 translocation.
Schmidt L; Li F; Brown RS; Berg S; Chen F; Wei MH; Tory K; Lerman I; Zbar B
Cancer J Sci Am; 1995; 1(3):191-5. PubMed ID: 9166475
[TBL] [Abstract][Full Text] [Related]
19. Remodeling epigenetic modifications at tumor suppressor gene promoters with bovine oocyte extract.
Wang Z; Yue Y; Han P; Sa R; Ren X; Wang J; Bai H; Yu H
Cytotherapy; 2013 Sep; 15(9):1164-73. PubMed ID: 23800731
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic silencing mediated by CpG island methylation: potential as a therapeutic target and as a biomarker.
Teodoridis JM; Strathdee G; Brown R
Drug Resist Updat; 2004; 7(4-5):267-78. PubMed ID: 15533764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
